ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 22 filers reported holding ESSA PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,424 | -72.0% | 178 | 0.0% | 0.00% | – |
| Q2 2021 | $5,085 | -1.7% | 178 | 0.0% | 0.00% | – |
| Q1 2021 | $5,171 | +143.5% | 178 | 0.0% | 0.00% | – |
| Q4 2020 | $2,124 | +73.0% | 178 | 0.0% | 0.00% | – |
| Q3 2020 | $1,228 | +11.2% | 178 | 0.0% | 0.00% | – |
| Q2 2020 | $1,104 | +55.1% | 178 | 0.0% | 0.00% | – |
| Q1 2020 | $712 | -27.3% | 178 | 0.0% | 0.00% | – |
| Q4 2019 | $979 | +63.2% | 178 | 0.0% | 0.00% | – |
| Q3 2019 | $600 | – | 178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
| Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
| Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
| MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
| Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
| PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
| Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
| Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |